386 related articles for article (PubMed ID: 19568240)
1. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.
Meng XN; Jin Y; Yu Y; Bai J; Liu GY; Zhu J; Zhao YZ; Wang Z; Chen F; Lee KY; Fu SB
Br J Cancer; 2009 Jul; 101(2):327-34. PubMed ID: 19568240
[TBL] [Abstract][Full Text] [Related]
2. Eupafolin regulates non-small-cell lung cancer cell proliferation,migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway.
Wang X; Huang M; Xie W; Ding Q; Wang T
J Biosci; 2023; 48():. PubMed ID: 36695419
[TBL] [Abstract][Full Text] [Related]
3. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
Park JH; Ryu JM; Han HJ
J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
[TBL] [Abstract][Full Text] [Related]
4. Delineating the signals by which repetitive deformation stimulates intestinal epithelial migration across fibronectin.
Gayer CP; Chaturvedi LS; Wang S; Alston B; Flanigan TL; Basson MD
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G876-85. PubMed ID: 19179620
[TBL] [Abstract][Full Text] [Related]
5. Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.
Kim HIe; Lee HS; Kim TH; Lee JS; Lee ST; Lee SJ
Oncotarget; 2015 Dec; 6(40):42905-22. PubMed ID: 26556867
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.
Piegeler T; Schläpfer M; Dull RO; Schwartz DE; Borgeat A; Minshall RD; Beck-Schimmer B
Br J Anaesth; 2015 Nov; 115(5):784-91. PubMed ID: 26475807
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
Yousif NG
Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
[TBL] [Abstract][Full Text] [Related]
10. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells.
Lee YC; Cheng TH; Lee JS; Chen JH; Liao YC; Fong Y; Wu CH; Shih YW
Mol Cell Biochem; 2011 Jan; 347(1-2):103-15. PubMed ID: 20963626
[TBL] [Abstract][Full Text] [Related]
11. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.
Thamilselvan V; Craig DH; Basson MD
FASEB J; 2007 Jun; 21(8):1730-41. PubMed ID: 17317726
[TBL] [Abstract][Full Text] [Related]
12. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
Li W; Liu Z; Zhao C; Zhai L
Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection.
Del Re DP; Miyamoto S; Brown JH
J Biol Chem; 2008 Dec; 283(51):35622-9. PubMed ID: 18854312
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
15. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
Luo Y; Liang F; Zhang ZY
Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
[TBL] [Abstract][Full Text] [Related]
16. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
17. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
18. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
[TBL] [Abstract][Full Text] [Related]
20. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
